159 related articles for article (PubMed ID: 30053964)
1. Time to treatment and survival in veterans with lung cancer eligible for curative intent therapy.
Ha D; Ries AL; Montgrain P; Vaida F; Sheinkman S; Fuster MM
Respir Med; 2018 Aug; 141():172-179. PubMed ID: 30053964
[TBL] [Abstract][Full Text] [Related]
2. Time to treatment in patients with stage III non-small cell lung cancer.
Wang L; Correa CR; Hayman JA; Zhao L; Cease K; Brenner D; Arenberg D; Curtis J; Kalemkerian GP; Kong FM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):790-5. PubMed ID: 19231108
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Timeliness of Care on Lung Cancer Survival - A Population-Based Approach.
Guerreiro T; Mayer A; Aguiar P; Araújo A; Nunes C
Ann Glob Health; 2023; 89(1):39. PubMed ID: 37304941
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
[TBL] [Abstract][Full Text] [Related]
5. Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer-results from a retrospective analysis.
Joosten PJM; Dickhoff C; van der Noort V; Smeekens M; Numan RC; Klomp HM; van Diessen JNA; Belderbos JSA; Smit EF; Monkhorst K; Oosterhuis JWA; van den Heuvel MM; Dahele M; Hartemink KJ
Interact Cardiovasc Thorac Surg; 2022 Mar; 34(4):566-575. PubMed ID: 34734237
[TBL] [Abstract][Full Text] [Related]
6. Induction chemoradiation is associated with improved survival in chest wall invasion lung cancer.
Muñoz-Largacha JA; Rao SR; Brinckerhoff LH; Daly BD; Fernando HC; Litle VR; Suzuki K
Tumori; 2019 Aug; 105(4):331-337. PubMed ID: 30905273
[TBL] [Abstract][Full Text] [Related]
7. Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients.
Moore S; Leung B; Wu J; Ho C
Radiat Oncol; 2020 Jan; 15(1):23. PubMed ID: 32000829
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and efficacy of salvage lung resection after definitive chemoradiation therapy for Stage III non-small-cell lung cancer.
Shimada Y; Suzuki K; Okada M; Nakayama H; Ito H; Mitsudomi T; Saji H; Takamochi K; Kudo Y; Hattori A; Mimae T; Aokage K; Nishii T; Tsuboi M; Ikeda N
Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):895-901. PubMed ID: 27543652
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
[TBL] [Abstract][Full Text] [Related]
10. Time to Curative-Intent Surgery in Gastric Cancer Shows a Bimodal Relationship with Overall Survival.
Kaslow SR; He Y; Sacks GD; Berman RS; Lee AY; Correa-Gallego C
J Gastrointest Surg; 2023 May; 27(5):855-865. PubMed ID: 36650415
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer.
Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
Thorac Cardiovasc Surg; 2018 Mar; 66(2):135-141. PubMed ID: 28992654
[TBL] [Abstract][Full Text] [Related]
12. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
[TBL] [Abstract][Full Text] [Related]
13. Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
J Cardiothorac Surg; 2016 Jan; 11():9. PubMed ID: 26781697
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemoradiation and surgery improves survival outcomes compared with definitive chemoradiation in the treatment of stage IIIA N2 non-small-cell lung cancer.
Darling GE; Li F; Patsios D; Massey C; Wallis AG; Coate L; Keshavjee S; Pierre A; De Perrot M; Yasufuku K; Cypel M; Waddell T
Eur J Cardiothorac Surg; 2015 Nov; 48(5):684-90; discussion 690. PubMed ID: 25567960
[TBL] [Abstract][Full Text] [Related]
15. Eight cases of salvage pulmonary resection for residual disease or isolated local recurrence detected after definitive chemoradiotherapy for N2 Stage-IIIA lung cancer.
Sawada S; Suehisa H; Ueno T; Yamashita M
Asian J Surg; 2017 Apr; 40(2):95-99. PubMed ID: 26362070
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society).
Couñago F; Rodriguez de Dios N; Montemuiño S; Jové-Teixidó J; Martin M; Calvo-Crespo P; López-Mata M; Samper-Ots MP; López-Guerra JL; García-Cañibano T; Díaz-Díaz V; de Ingunza-Barón L; Murcia-Mejía M; Alcántara P; Corona J; Puertas MM; Chust M; Couselo ML; Del Cerro E; Moradiellos J; Amor S; Varela A; Thuissard IJ; Sanz-Rosa D; Taboada B
Lung Cancer; 2018 Apr; 118():119-127. PubMed ID: 29571989
[TBL] [Abstract][Full Text] [Related]
17. How Much Delay Matters? How Time to Treatment Impacts Overall Survival in Early Stage Lung Cancer.
Tang A; Ahmad U; Raja S; Bribriesco AC; Sudarshan M; Rappaport J; Khorana A; Blackstone EH; Murthy SC; Raymond DP
Ann Surg; 2023 Apr; 277(4):e941-e947. PubMed ID: 34793347
[TBL] [Abstract][Full Text] [Related]
18. Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer.
Yang CF; Adil SM; Anderson KL; Meyerhoff RR; Turley RS; Hartwig MG; Harpole DH; Tong BC; Onaitis MW; D'Amico TA; Berry MF
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1607-13. PubMed ID: 26719403
[TBL] [Abstract][Full Text] [Related]
19. Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes.
Bauman JE; Mulligan MS; Martins RG; Kurland BF; Eaton KD; Wood DE
Ann Thorac Surg; 2008 Nov; 86(5):1632-8; discussion 1638-9. PubMed ID: 19049763
[TBL] [Abstract][Full Text] [Related]
20. Chemoradiation treatment patterns among United States Veteran Health Administration patients with unresectable stage III non-small cell lung cancer.
Hung A; Lee KM; Lynch JA; Li Y; Poonnen P; Efimova OV; Hintze BJ; Buckingham T; Yong C; Seal B; Kelley MJ; Reed SD
BMC Cancer; 2021 Jul; 21(1):824. PubMed ID: 34271861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]